Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents Guided by Either Intravascular Ultrasound or Angiography in Patients With Acute Coronary Syndrome: The Prospective, Multicenter, Randomized, Placebo-controlled IVUS-ACS and ULTIMATE-DAPT Trials
Latest Information Update: 22 Feb 2024
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes; Thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms IVUS-ACS & ULTIMATE-DAPT
Most Recent Events
- 16 Feb 2024 Planned End Date changed from 30 Sep 2024 to 30 Dec 2025.
- 27 Oct 2022 Planned primary completion date changed from 30 Sep 2022 to 27 Oct 2023.
- 27 Oct 2022 Status changed from recruiting to active, no longer recruiting.